Consolidated Statements of Stockholders' Equity (audited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income, Net of Tax	Accumulated Deficit
Balance at Dec. 31, 2023	$ 89,420	$ 1	$ 400,741	$ 33	$ (311,355)
Balance, Shares at Dec. 31, 2023		1,144,291
Exercise of common stock options	3		3
Exercise of common stock options, Shares		21
Issuance of common stock and pre-funded warrants, net of issuance costs	10		10
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares		114,927
Issuance of common stock upon RSU vesting, shares		1,731
Shares issued under ATM, net of issuance costs	4,850		4,850
Shares issued under ATM, net of issuance costs, Shares		20,833
Issuance of common stock under ESPP		20
Issuance of common stock upon exercise of common stock warrants	3,808		3,808
Issuance of common stock upon exercise of common stock warrants, Shares		28,485
Unrealized loss on available-for-sale securities	(33)			$ (33)
Stock-based compensation	6,971		6,971
Net loss	(93,435)				(93,435)
Balance at Dec. 31, 2024	$ 11,594	$ 1	416,383		(404,790)
Balance, Shares at Dec. 31, 2024		1,310,308
Decrease in common stock for rounding down of fractional shares to reflect the 1-for -50 reverse stock split		(48)
Exercise of common stock options, Shares	0
Issuance of common stock and pre-funded warrants, net of issuance costs	$ 4,273	$ 1	4,272
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares		273,012
Issuance of common stock upon exercise of pre-funded warrants, Shares		150,360
Issuance of common stock upon RSU vesting, shares		41,250
Stock-based compensation	2,335		2,335
Net loss	(28,919)				(28,919)
Balance at Dec. 31, 2025	$ (10,717)	$ 2	$ 422,990		$ (433,709)
Balance, Shares at Dec. 31, 2025		1,774,882